Stock price Illumina Inc (ILMN) today

Illumina Inc

Illumina Inc


High: 319.81

Low: 0

Illumina Inc. is a global US-based developer, manufacturer, and distributor of systems that enable researchers to carry out the genetic research needed for medicine, genomics, and proteomics. Its customers include genomic research centers, pharmaceutical companies, research institutions, clinical research organizations, and biotechnology companies.

Illumina was founded in 1998, in 2000 it carried out an IPO becoming a public company and issuing shares on the NASDAQ.

Since 2001, it began to produce equipment for the genotyping of single nucleotide polymorphisms; in 2002, it launched the Illumina BeadLab system. In 2007, it was acquired by Solexa, Inc. Until 2010, Illumina sold instruments labeled research-only", in 2010 the company received FDA approval for its BeadXpress system for use in clinical trials, after which its own CLIA laboratory was opened. In 2011, it was acquired by Epicenter Biotechnologies, in 2018 - Pacific Biosciences for $ 1.2 billion. The company is part of the NASDAQ-100 and S & P 500.

This week's events

Time Country Period Event Sense Forecast Previous
February 17, 2020
Day USD calender forex Bank Holiday
Name Current price Last Change
10+ Year Government/Credit Bond Ishares 72.55
Imax Corp 21.55000000
Immune Design Corp 5.85000000
Immunogen 3.89000000
Impac Mortgage Holdings 5.60000000

The ratio between two currencies determined on the basis of the exchange rate of these currencies in relation to a third currency; carried out mainly in relation to the US dollar. When trading with cross rates, one needs to use the fundamental analysis of world markets, as well as the indicators of the US, Europe and Asia financial markets.

The distribution of invested funds among various objects (financial instruments and markets) in order to reduce the risk of possible losses of either fixed capital or profits.

This means that the investor buys financial assets counting on the growth of their value and profit from their sale. This term is derived from the established opinion that the stock market has a long-term upward trend, and thus, over a long period of time, the price of the once-purchased shares will inevitably increase.

Important notice
By clicking "Continue" you will be redirected to the website operated by FIBO Group Holdings Limited, a company registered in Cyprus and regulated by CySEC. Please familiarize yourself with the Terms of Business through the link. Click "Cancel" to remain on this page.